Clinical Trial Update: A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment

View source ↗

Summary

The clinical trial sponsored by Amgen evaluated apremilast in biologic-naïve patients with psoriatic arthritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Arthritis, Psoriatic | Status: COMPLETED